Riff on every idea. Ship the ones that land.
Riffcheck turns a brief into a production-quality animatic and reads it against a synthetic audience — HCPs, patients, or your target consumer — so you back the winning take before you spend a dollar producing it.
First 60-second test free — first 50 sign-ups, work email · built for pharma, biotech & agencies.
Riffcheck makes testing cheap and fast enough to run on every concept. Screen twenty routes, kill the losers before production, and walk into the room — or into MLR — with evidence instead of opinion.
See the quality.
A 60-second animatic produced with the Riffcheck pipeline — the kind of polished, testable film a brief becomes.
▶ Watch the 60-second sample
Sample produced with the Riffcheck pipeline for a UniteRare LLC project.
From first riff to the winning take.
Five steps, one console. Every guardrail — moderation, regulated-claim flags, AI-disclosure — runs automatically, so your team drives it end to end.
Brief
Product, audience, message, tone, length. A regulated-claim check runs on the way in.
Animatic
An editable storyboard becomes a polished animatic — characters, voiceover, score.
Synthetic panel
Screen it against configurable segments: cardiologists, patients 55+, brand-team, consumers.
Signal
Scores by segment, the lines that land, the moments that lose people, ranked fixes.
Riff again
One click rebuilds the next take with the fixes applied. Iterate until the signal is strong.
The whole workflow, self-serve.
No account managers, no waiting on a research vendor. This is the actual interface your team works in — click through it.
Six shots, editable. Swap a line, reorder, or lock a frame before rendering.
Each persona is built from a deterministic segment grid, reacts independently, and returns structured scores plus open-ended read. No two are alike.
Two audiences, one instrument.
Test the message before MLR — and before the media buy.
- Read HCP and patient reactions by specialty and line before committing spend.
- Prompts that surface common review considerations — fair balance, possible off-label cues — for your MLR team's own evaluation, with a full audit trail. Not a compliance check.
- In-silico is already your language — synthetic pre-screening fits how you de-risk.
- Kill weak routes early; take only the concepts worth your team's time into review.
Walk into the pitch with evidence, not a hunch.
- Screen twenty creative routes overnight; bring the client the two that survive.
- Segment reads that show who a concept wins and where it loses them.
- Benchmark against category norms only a neutral third party can offer.
- Refine in minutes — iterate the idea before a single production dollar is spent.